mazindol has been researched along with Anxiety in 2 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enzi, G | 1 |
| Baritussio, A | 1 |
| Marchiori, E | 1 |
| Crepaldi, G | 1 |
| Bruera, E | 1 |
| Carraro, S | 1 |
| Roca, E | 1 |
| Barugel, M | 1 |
| Chacon, R | 1 |
2 trials available for mazindol and Anxiety
| Article | Year |
|---|---|
Short-term and long-term clinical evaluation of a non-amphetaminic anorexiant (mazindol) in the treatment of obesity.
Topics: Adolescent; Adult; Anxiety; Diet, Reducing; Drug Evaluation; Glucose Tolerance Test; Humans; Indoles | 1976 |
Double-blind evaluation of the effects of mazindol on pain, depression, anxiety, appetite, and activity in terminal cancer patients.
Topics: Anxiety; Appetite; Clinical Trials as Topic; Depression; Female; Humans; Indoles; Male; Mazindol; Mi | 1986 |